After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than 2022 Over 17,000 surgical procedures completed using Versius, representing a procedural growth ...
Globally, Versius is the second most utilized surgical robotic system, withover26,000 surgical procedures completed across Europe, Latin America, Asia, Middle East and Africa With its unique compact ...
CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
CMR Surgical is launching a new imaging technology to help users of its Versius robot visualize the flow of blood through organs during a procedure. The company’s vLimeLite add-on incorporates a ...
CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback